Oncology & Cancer

Brain cancer vaccine effective in some patients

Most people with the deadly brain cancer glioblastoma die less than 18 months after diagnosis. But a multicenter clinical trial of a personalized vaccine that targets the aggressive cancer has indicated improved survival ...

Oncology & Cancer

New cancer vaccine one step closer

A team led by Monash University and the University of Queensland has developed a new approach to harnessing the body's immune system to fight disease that could pave the way for a new class of cancer vaccine.

HIV & AIDS

Research offers a new approach to improving HIV vaccines

In a scientific discovery that has significant implications for preventing HIV infections, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified a protein that could improve the body's ...

Oncology & Cancer

New cancer vaccine approach directly targets dendritic cells

Celldex Therapeutics announced today that final data from its Phase 1 study of CDX-1401 in solid tumors, including long-term patient follow-up, have been published in Science Translational Medicine. The data demonstrate robust ...

page 3 from 5